🔎 Trials Near Me

홈 › 췌장암 › 텍사스

텍사스의 췌장암 임상 시험

췌장암 관련 연구 79개가 텍사스 내 여러 지역에서 참여자를 모집하고 있습니다.

텍사스의 도시

공식 연구 텍스트(영어)

Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

  • SCRI - Texas Oncology Dallas, Dallas
  • MD Anderson Cancer Center, Houston
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07491445

A Study of PHN-012 in Patients With Advanced Solid Tumors

  • PHN-012-001 Site, Houston
  • PHN-012-001 Site, San Antonio
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07127874

Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )

  • University of Texas MD Anderson Cancer Center, Houston
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07621718

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

  • START Dallas Fort Worth, Fort Worth
  • MD Anderson, Houston
  • NEXT Oncology Houston, Houston
  • 외 1개
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07277413

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

  • University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
  • University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas
  • University of Texas Southwestern Medical Center-Zale Lipshy University Hospital, Dallas
  • 외 3개
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06989437

DESTINY-PANTUMOUR04

  • Research Site, Dallas
피험자 모집 중관찰 연구
18세 ~ 130세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07124000

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

  • Texas Oncology - West Texas, Abilene
  • Texas Oncology - Austin, Austin
  • Texas Oncology - San Antonio, San Antonio
  • 외 1개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07562152

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • The University of Texas MD Anderson Cancer Center, Houston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06172478

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

  • Texas Oncology - DFW, Dallas
  • University of Texas, Southwestern Medical Center, Dallas
  • University of Texas MD Anderson Cancer Center, Houston
  • 외 1개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07252232

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • MD Anderson, Houston
  • NEXT Dallas, Irving
  • NEXT Oncology San Antonio, San Antonio
  • 외 1개
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06128551

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

  • UT Southwestern Medical Center at Dallas, Dallas
  • Houston Methodist Office of Graduate - Houston Methodist Neal Cancer Center at Texas Medical Center, Houston
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07409272

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

  • Investigative Site US067, Dallas
  • Investigative Site US062, Denison
  • Investigative Site US011, Houston
  • 외 2개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07522073

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

  • Baylor College of Medicine, Houston
  • The University of Texas MD Anderson Cancer Center, Houston
  • NEXT Oncology Dallas, Irving
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06445062

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

  • The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT07629960

Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts

  • The University of Texas MD Anderson Cancer Center, Houston
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT06271291

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

  • NEXT - Dallas, Dallas
  • NEXT, San Antonio
  • START - San Antonio, San Antonio
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07349537

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

  • Local Institution - 0085, Houston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT07492680

CREO - Microwave Ablation Feasibility Study

  • Memorial Hermann-Texas Medical Center, Houston
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT07817147

Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study

  • University of Texas Southwestern/Children's Medical Center, Dallas
  • M D Anderson Cancer Center, Houston
  • Texas Children's Hospital, Houston
  • 외 1개
피험자 모집 중관찰 연구
17세 이하 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT06651580

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

  • UT MD Anderson, Houston
  • NEXT Oncology, San Antonio
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT06440005

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
피험자 모집 중관찰 연구
50세 ~ 75세 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT04239573

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

  • The University of Texas - MD Anderson Cancer Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT06400472

iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

  • M D Anderson Cancer Center, Houston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT03608631

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • University of Texas MD Anderson Cancer Center, Houston
  • South Texas Accelerated Research Therapeutics (START), San Antonio
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT06465069

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

  • UT MD Anderson Cancer Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT05372614

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

  • The University of Texas MD Anderson Cancer Center - Conroe, Conroe
  • University of Texas MD Anderson Cancer Center, Houston
  • The University of Texas, MD Anderson Cancer Center - West Houston, Houston
  • 외 3개
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT07090499

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

  • START Dallas, Fort Worth
  • MD Anderson Cancer Center, Houston
  • START- San Antonio, San Antonio
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT07644559

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  • The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06760819

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

  • Ut Southwestern, Dallas
  • Texas Oncology - DFW, Fort Worth
  • MDACC, Houston
  • 외 2개
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT05245500

PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)

  • University of Texas Southwestern Medical Center, Dallas
  • The University of Texas MD Anderson Cancer Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT06673017

Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer

  • Texas Oncology, Houston
  • Baylor College of Medicine, Houston
  • University Cancer and Diagnostic, Houston
피험자 모집 중
18세 ~ 120세 · 모든 성별 · 2026. 8. 27. 업데이트됨 · NCT06698458

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

  • START San Antonio, San Antonio
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 27. 업데이트됨 · NCT06582017

Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma

  • Baylor College of Medicine Medical Center - McNair Campus, Houston
  • Baylor St. Lukes Medical Center, Houston
  • Dan L. Duncan Cancer Center at Baylor College of Medicine, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 26. 업데이트됨 · NCT04157127

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

  • Houston Methodist San Jacinto Hospital, Baytown
  • UT MD Anderson - The Woodlands, Conroe
  • Houston Methodist Cypress Hospital, Cypress
  • 외 16개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT06958328

A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer.

  • Oncology Consultants, P.A., Houston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT07157033

A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

  • MD Anderson Cancer Center, Houston
  • NEXT Dallas, Irving
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 13. 업데이트됨 · NCT07066657

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

  • Research Site, Houston
  • Research Site, San Antonio
피험자 모집 중1/2상
18세 ~ 130세 · 모든 성별 · 2026. 8. 12. 업데이트됨 · NCT05417594

A Study of MGC026 in Participants With Advanced Solid Tumors

  • The University of Texas MD Anderson Cancer Center, Houston
  • University of Texas Health Science Center at Houston, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT06242470

A Study of DM002 in Patients With Advanced Solid Tumors

  • The University of Texas, MD Anderson Cancer Center, Houston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 7. 업데이트됨 · NCT06751329

Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)

  • Excel Diagnostics & Nuclear Oncology Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 7. 업데이트됨 · NCT07733674

ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.